Brief: Xoma Royalty Buys Mezagitamab Royalty, Milestone Rights Held By Bioinvent For Up To $30 Mln
27/05/2025 13:06
May 27 (Reuters) - BioInvent International AB BINV.ST: XOMA ROYALTY PURCHASES MEZAGITAMAB ROYALTY AND MILESTONE RIGHTS HELD BY BIOINVENT INTERNATIONAL FOR UP TO USD 30 MILLION XOMA ROYALTY HAS PURCHASED FUTURE MEZAGITAMAB ROYALTY AND MILESTONE INTERESTS HELD BY BIOINVENT FOR USD $20 MILLION AT CLOSING TOTAL TRANSACTION OF UP TO USD $30 MILLION Source text: ID:nMFN8lKzm2 Further company coverage: BINV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))